23 Oct Biden-Harris Administration Designates Tech Hub in Wisconsin to Promote Innovation in Personalized Medicine
As part of the President’s Investing in America agenda, the U.S. Department of Commerce identifies regional centers primed for innovation and job creation.
WASHINGTON, DC — The Biden-Harris administration, through the U.S. Department of Commerce’s Economic Development Administration (EDA), today announced that Wisconsin Biohealth Tech Hub in Wisconsin was designated as one of the 31 inaugural Tech Hubs in regions across the country that show potential for rapid growth in key technology sectors.
The Wisconsin Biohealth Tech Hub, a consortium led by Bioforward Wisconsin, will work to position Wisconsin as a global leader in personalized medicine. Leverage its cluster of healthcare assets and track record of commercializing medical research, the Wisconsin Biohealth Tech Hub will facilitate manufacturing coordination and data sharing, expand lab space and computing capacity, advance genomic technology, and accelerate domestic biotech manufacturing.
This designation is part of the first phase of the novel Tech Hubs program, authorized by the CHIPS and Science Act, that will invest directly in high-potential U.S. regions and aim to transform them into globally competitive innovation centers. Designation is an endorsement of the region’s strategy to supercharge their respective technological industry to create jobs and strengthen U.S. economic and national security. Designated Tech Hubs are now eligible to apply for the next phase of the Tech Hubs Program that will invest between $50-$75 million in each of 5-10 Designated Hubs.
In addition to a Tech Hubs Designation, EDA announced today that Wisconsin Biohealth Tech Hub was also awarded a Tech Hubs Strategy Development Grant that will help the consortium increase local coordination and planning activities to strengthen its region’s capacity to manufacture, commercialize, and deploy critical technologies.